Small cell lung cancer with mutations in the ALK gene is a special disease that requires treatment with a specific drug called alectinib. This active ingredient is in the drug Alecensa.

Alectinib is a Multikinase inhibitor, specifically used primarily in non-small cell lung cancer with mutations in the ALK gene. So what does Alectinib actually do and what issues should patients pay attention to during treatment?